ResearcherFondazione IRCCS Istituto Nazionale dei TumoriActive in the last 2 years

Davide Citterio

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0708-8733; OpenAlex author ID A5054468073. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Multicenter IGoMIPS Registry-based analysis of robotic versus laparoscopic approach to left pancreatectomy for pancreatic cancer. Co-author DOI 10.1007/s13304-026-02831-3 ↗
Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. Co-author DOI 10.1016/j.suronc.2025.102208 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Andrea Zironda · 1 shared paper, 2025 · strength 0.23
- Paper Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. DOI 10.1016/j.suronc.2025.102208 ↗
Michele Mazzola · 1 shared paper, 2025 · strength 0.23
- Paper Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. DOI 10.1016/j.suronc.2025.102208 ↗
Vincenzo Mazzaferro · 1 shared paper, 2025 · strength 0.23
- Paper Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. DOI 10.1016/j.suronc.2025.102208 ↗
Giovanni Carlo Ferrari · 1 shared paper, 2025 · strength 0.23
- Paper Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. DOI 10.1016/j.suronc.2025.102208 ↗
Samuele Grandi · 1 shared paper, 2025 · strength 0.23
- Paper Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. DOI 10.1016/j.suronc.2025.102208 ↗
Giuseppe Leoncini · 1 shared paper, 2025 · strength 0.23
- Paper Prediction of early recurrence as a marker of surgical futility in pancreatic adenocarcinoma. DOI 10.1016/j.suronc.2025.102208 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.